English

BIOSPECIFICS TECHNOLOGIES CORP

EDGAR

BSTC Filing (4) · filed 2020-12-02

121 filing records in this dataset, filed from 1996-06-14 to 2020-12-02. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

11.3 million Unit_Standard_USD_fy74FWNqD0qKjv7uRDHJsg

2020 Q3 · Unit_Standard_USD_fy74FWNqD0qKjv7uRDHJsg

Exact inputs and evidence

Revenue: 11255864 Unit_Standard_USD_fy74FWNqD0qKjv7uRDHJsg Source

Operating margin

57.85%

2020 Q3 · %

Exact inputs and evidence

Operating Income: 6511930 Unit_Standard_USD_fy74FWNqD0qKjv7uRDHJsg Source
Revenue: 11255864 Unit_Standard_USD_fy74FWNqD0qKjv7uRDHJsg Source

Cash and cash equivalents: 2.87 million Unit_Standard_USD_fy74FWNqD0qKjv7uRDHJsg 2020-09-30 Source
Exact value

2873726 Unit_Standard_USD_fy74FWNqD0qKjv7uRDHJsg
Long-term debt including current maturities: Not available
Shares outstanding: 7.34 million Unit_Standard_shares_zaEYdvTzWEeB8UM7MxWu_w 2020-09-30 Source
Exact value

7344955 Unit_Standard_shares_zaEYdvTzWEeB8UM7MxWu_w

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2020-12-02.

Financial data available through: 2019-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2019-12-31
Operating income: 11 of 11 periods available· newest 2019-12-31
Net income: 11 of 11 periods available· newest 2019-12-31
Operating cash flow: 11 of 11 periods available· newest 2019-12-31
capital expenditure: No compatible figures in this window
Total assets: Multiple units; comparison withheld· newest 2019-12-31
Total liabilities: Multiple units; comparison withheld· newest 2019-12-31
Current assets: Multiple units; comparison withheld· newest 2019-12-31
Current liabilities: Multiple units; comparison withheld· newest 2019-12-31
Cash and cash equivalents: Multiple units; comparison withheld· newest 2019-12-31
long term debt: No compatible figures in this window
Shares outstanding: Multiple units; comparison withheld· newest 2019-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+15.9%

Prior period

U001 32.96 million

2018-01-01 – 2018-12-31
Current period

U001 38.19 million

2019-01-01 – 2019-12-31

Exact inputs and evidence

38187755 − 32961443 = 5226312 U001

32961443 U001 · 2018-01-01 – 2018-12-31
Inspect prior input Prior source
38187755 U001 · 2019-01-01 – 2019-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · BIOSPECIFICS TECHNOLOGIES CORP · 2019-12-31 BIOSPECIFICS TECHNOLOGIES CORP (edgar:875622) Year-over-year change in Revenue: 5226312 U001 Concept: fundies:Revenue Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/875622?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 38187755 U001 (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036120005848/bstc-20191231.xml#592789 Filing: 000114036120005848 Input fundies:Revenue: 32961443 U001 (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036120005848/bstc-20191231.xml#592527 Filing: 000114036120005848
The citation records this snapshot. The page link may show a newer release later.
Net income
+22%

Prior period

U001 20.05 million

2018-01-01 – 2018-12-31
Current period

U001 24.47 million

2019-01-01 – 2019-12-31

Exact inputs and evidence

24469808 − 20053269 = 4416539 U001

20053269 U001 · 2018-01-01 – 2018-12-31
Inspect prior input Prior source
24469808 U001 · 2019-01-01 – 2019-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · BIOSPECIFICS TECHNOLOGIES CORP · 2019-12-31 BIOSPECIFICS TECHNOLOGIES CORP (edgar:875622) Year-over-year change in Net income: 4416539 U001 Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/875622?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 24469808 U001 (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036120005848/bstc-20191231.xml#552964 Filing: 000114036120005848 Input fundies:NetIncome: 20053269 U001 (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036120005848/bstc-20191231.xml#552752 Filing: 000114036120005848
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+25.7%

Prior period

U001 17.73 million

2018-01-01 – 2018-12-31
Current period

U001 22.29 million

2019-01-01 – 2019-12-31

Exact inputs and evidence

22285149 − 17730536 = 4554613 U001

17730536 U001 · 2018-01-01 – 2018-12-31
Inspect prior input Prior source
22285149 U001 · 2019-01-01 – 2019-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · BIOSPECIFICS TECHNOLOGIES CORP · 2019-12-31 BIOSPECIFICS TECHNOLOGIES CORP (edgar:875622) Year-over-year change in Operating cash flow: 4554613 U001 Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/875622?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 22285149 U001 (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036120005848/bstc-20191231.xml#551077 Filing: 000114036120005848 Input fundies:OperatingCashFlow: 17730536 U001 (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036120005848/bstc-20191231.xml#551358 Filing: 000114036120005848
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2019 2019-01-01 – 2019-12-31

Revenue U001 38.19 million 100% of revenue
Operating costs Derived U001 9.88 million 26% of revenue
Operating income U001 28.31 million 74% of revenue
Tax, interest and other Derived U001 3.84 million 10% of revenue
Net income U001 24.47 million 64% of revenue

Cash

Operating cash flow U001 22.29 million 58% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2010 Operating loss: operating costs were 136% of revenue.
2011 Net income was higher than operating income, so the split is not drawn.
2012 27%19%54%
2013 37%18%45%
2014 33%17%50%
2015 42%21%37%
2016 43%22%35%
2017 41%23%36%
2018 61%10%29%
2019 64%10%26%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2010 2010-01-01 – 2010-12-31	5661348	7694380 Derived	-2033032	-524492 Derived	-1508540	Unavailable	Source 2010-01-01 – 2010-12-31: 5661348 U001 Inspect Revenue Open source 2010-01-01 – 2010-12-31: -2033032 U001 Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -1508540 U001 Inspect Net Income Open source 2010-01-01 – 2010-12-31: -882482 U001 Inspect Operating Cash Flow Open source
2011 2011-01-01 – 2011-12-31	11395726	6203959 Derived	5191767	-1409859 Derived	6601626	Unavailable	Source 2011-01-01 – 2011-12-31: 11395726 U001 Inspect Revenue Open source 2011-01-01 – 2011-12-31: 5191767 U001 Inspect Operating Income Open source 2011-01-01 – 2011-12-31: 6601626 U001 Inspect Net Income Open source 2011-01-01 – 2011-12-31: -687589 U001 Inspect Operating Cash Flow Open source
2012 2012-01-01 – 2012-12-31	11145078	6024583 Derived	5120495	2139420 Derived	2981075	Unavailable	Source 2012-01-01 – 2012-12-31: 11145078 U001 Inspect Revenue Open source 2012-01-01 – 2012-12-31: 5120495 U001 Inspect Operating Income Open source 2012-01-01 – 2012-12-31: 2981075 U001 Inspect Net Income Open source 2012-01-01 – 2012-12-31: 930433 U001 Inspect Operating Cash Flow Open source
2013 2013-01-01 – 2013-12-31	14429782	6522779 Derived	7907003	2621156 Derived	5285847	Unavailable	Source 2013-01-01 – 2013-12-31: 14429782 U001 Inspect Revenue Open source 2013-01-01 – 2013-12-31: 7907003 U001 Inspect Operating Income Open source 2013-01-01 – 2013-12-31: 5285847 U001 Inspect Net Income Open source 2013-01-01 – 2013-12-31: 4535549 U001 Inspect Operating Cash Flow Open source
2014 2014-01-01 – 2014-12-31	14044624	7077697 Derived	6966927	2320967 Derived	4645960	Unavailable	Source 2014-01-01 – 2014-12-31: 14044624 U001 Inspect Revenue Open source 2014-01-01 – 2014-12-31: 6966927 U001 Inspect Operating Income Open source 2014-01-01 – 2014-12-31: 4645960 U001 Inspect Net Income Open source 2014-01-01 – 2014-12-31: 6129176 U001 Inspect Operating Cash Flow Open source
2015 2015-01-01 – 2015-12-31	22750135	8306820 Derived	14443315	4825683 Derived	9617632	Unavailable	Source 2015-01-01 – 2015-12-31: 22750135 U001 Inspect Revenue Open source 2015-01-01 – 2015-12-31: 14443315 U001 Inspect Operating Income Open source 2015-01-01 – 2015-12-31: 9617632 U001 Inspect Net Income Open source 2015-01-01 – 2015-12-31: 10606660 U001 Inspect Operating Cash Flow Open source
2016 2016-01-01 – 2016-12-31	26250955	9224539 Derived	17026416	5654177 Derived	11372239	Unavailable	Source 2016-01-01 – 2016-12-31: 26250955 U001 Inspect Revenue Open source 2016-01-01 – 2016-12-31: 17026416 U001 Inspect Operating Income Open source 2016-01-01 – 2016-12-31: 11372239 U001 Inspect Net Income Open source 2016-01-01 – 2016-12-31: 16352349 U001 Inspect Operating Cash Flow Open source
2017 2017-01-01 – 2017-12-31	27443752	9765601 Derived	17678151	6349885 Derived	11328266	Unavailable	Source 2017-01-01 – 2017-12-31: 27443752 U001 Inspect Revenue Open source 2017-01-01 – 2017-12-31: 17678151 U001 Inspect Operating Income Open source 2017-01-01 – 2017-12-31: 11328266 U001 Inspect Net Income Open source 2017-01-01 – 2017-12-31: 13157654 U001 Inspect Operating Cash Flow Open source
2018 2018-01-01 – 2018-12-31	32961443	9562765 Derived	23398678	3345409 Derived	20053269	Unavailable	Source 2018-01-01 – 2018-12-31: 32961443 U001 Inspect Revenue Open source 2018-01-01 – 2018-12-31: 23398678 U001 Inspect Operating Income Open source 2018-01-01 – 2018-12-31: 20053269 U001 Inspect Net Income Open source 2018-01-01 – 2018-12-31: 17730536 U001 Inspect Operating Cash Flow Open source
2019 2019-01-01 – 2019-12-31	38187755	9875703 Derived	28312052	3842244 Derived	24469808	Unavailable	Source 2019-01-01 – 2019-12-31: 38187755 U001 Inspect Revenue Open source 2019-01-01 – 2019-12-31: 28312052 U001 Inspect Operating Income Open source 2019-01-01 – 2019-12-31: 24469808 U001 Inspect Net Income Open source 2019-01-01 – 2019-12-31: 22285149 U001 Inspect Operating Cash Flow Open source

Amounts are exact, in U001.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

U001 38.2M 2019

Values and sources

Revenue values and source evidence
Period	Series	Value(U001)	Source evidence
20102010-12-31	Revenue	5661348	Revenue: 5661348 Open source
20112011-12-31	Revenue	11395726	Revenue: 11395726 Open source
20122012-12-31	Revenue	11145078	Revenue: 11145078 Open source
20132013-12-31	Revenue	14429782	Revenue: 14429782 Open source
20142014-12-31	Revenue	14044624	Revenue: 14044624 Open source
20152015-12-31	Revenue	22750135	Revenue: 22750135 Open source
20162016-12-31	Revenue	26250955	Revenue: 26250955 Open source
20172017-12-31	Revenue	27443752	Revenue: 27443752 Open source
20182018-12-31	Revenue	32961443	Revenue: 32961443 Open source
20192019-12-31	Revenue	38187755	Revenue: 38187755 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

15.9% 2019

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20102010-12-31	Year over year	79.4%	Revenue: 5661348 Open source Revenue: 3155757 Open source
20112011-12-31	Year over year	101.3%	Revenue: 11395726 Open source Revenue: 5661348 Open source
20122012-12-31	Year over year	-2.2%	Revenue: 11145078 Open source Revenue: 11395726 Open source
20132013-12-31	Year over year	29.5%	Revenue: 14429782 Open source Revenue: 11145078 Open source
20142014-12-31	Year over year	-2.7%	Revenue: 14044624 Open source Revenue: 14429782 Open source
20152015-12-31	Year over year	62%	Revenue: 22750135 Open source Revenue: 14044624 Open source
20162016-12-31	Year over year	15.4%	Revenue: 26250955 Open source Revenue: 22750135 Open source
20172017-12-31	Year over year	4.5%	Revenue: 27443752 Open source Revenue: 26250955 Open source
20182018-12-31	Year over year	20.1%	Revenue: 32961443 Open source Revenue: 27443752 Open source
20192019-12-31	Year over year	15.9%	Revenue: 38187755 Open source Revenue: 32961443 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 74.1% 2019

Net margin 64.1% 2019

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20102010-12-31	Operating margin	-35.9%	Operating Income: -2033032 Open source Revenue: 5661348 Open source
20112011-12-31	Operating margin	45.6%	Operating Income: 5191767 Open source Revenue: 11395726 Open source
20122012-12-31	Operating margin	45.9%	Operating Income: 5120495 Open source Revenue: 11145078 Open source
20132013-12-31	Operating margin	54.8%	Operating Income: 7907003 Open source Revenue: 14429782 Open source
20142014-12-31	Operating margin	49.6%	Operating Income: 6966927 Open source Revenue: 14044624 Open source
20152015-12-31	Operating margin	63.5%	Operating Income: 14443315 Open source Revenue: 22750135 Open source
20162016-12-31	Operating margin	64.9%	Operating Income: 17026416 Open source Revenue: 26250955 Open source
20172017-12-31	Operating margin	64.4%	Operating Income: 17678151 Open source Revenue: 27443752 Open source
20182018-12-31	Operating margin	71%	Operating Income: 23398678 Open source Revenue: 32961443 Open source
20192019-12-31	Operating margin	74.1%	Operating Income: 28312052 Open source Revenue: 38187755 Open source
20102010-12-31	Net margin	-26.6%	Net Income: -1508540 Open source Revenue: 5661348 Open source
20112011-12-31	Net margin	57.9%	Net Income: 6601626 Open source Revenue: 11395726 Open source
20122012-12-31	Net margin	26.7%	Net Income: 2981075 Open source Revenue: 11145078 Open source
20132013-12-31	Net margin	36.6%	Net Income: 5285847 Open source Revenue: 14429782 Open source
20142014-12-31	Net margin	33.1%	Net Income: 4645960 Open source Revenue: 14044624 Open source
20152015-12-31	Net margin	42.3%	Net Income: 9617632 Open source Revenue: 22750135 Open source
20162016-12-31	Net margin	43.3%	Net Income: 11372239 Open source Revenue: 26250955 Open source
20172017-12-31	Net margin	41.3%	Net Income: 11328266 Open source Revenue: 27443752 Open source
20182018-12-31	Net margin	60.8%	Net Income: 20053269 Open source Revenue: 32961443 Open source
20192019-12-31	Net margin	64.1%	Net Income: 24469808 Open source Revenue: 38187755 Open source
20102010-12-31	Free cash flow margin	Not reported	Revenue: 5661348 Open source Operating Cash Flow: -882482 Open source
20112011-12-31	Free cash flow margin	Not reported	Revenue: 11395726 Open source Operating Cash Flow: -687589 Open source
20122012-12-31	Free cash flow margin	Not reported	Revenue: 11145078 Open source Operating Cash Flow: 930433 Open source
20132013-12-31	Free cash flow margin	Not reported	Revenue: 14429782 Open source Operating Cash Flow: 4535549 Open source
20142014-12-31	Free cash flow margin	Not reported	Revenue: 14044624 Open source Operating Cash Flow: 6129176 Open source
20152015-12-31	Free cash flow margin	Not reported	Revenue: 22750135 Open source Operating Cash Flow: 10606660 Open source
20162016-12-31	Free cash flow margin	Not reported	Revenue: 26250955 Open source Operating Cash Flow: 16352349 Open source
20172017-12-31	Free cash flow margin	Not reported	Revenue: 27443752 Open source Operating Cash Flow: 13157654 Open source
20182018-12-31	Free cash flow margin	Not reported	Revenue: 32961443 Open source Operating Cash Flow: 17730536 Open source
20192019-12-31	Free cash flow margin	Not reported	Revenue: 38187755 Open source Operating Cash Flow: 22285149 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

U001 22.3M 2019

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(U001)	Source evidence
20102010-12-31	Operating cash flow	-882482	Operating Cash Flow: -882482 Open source
20112011-12-31	Operating cash flow	-687589	Operating Cash Flow: -687589 Open source
20122012-12-31	Operating cash flow	930433	Operating Cash Flow: 930433 Open source
20132013-12-31	Operating cash flow	4535549	Operating Cash Flow: 4535549 Open source
20142014-12-31	Operating cash flow	6129176	Operating Cash Flow: 6129176 Open source
20152015-12-31	Operating cash flow	10606660	Operating Cash Flow: 10606660 Open source
20162016-12-31	Operating cash flow	16352349	Operating Cash Flow: 16352349 Open source
20172017-12-31	Operating cash flow	13157654	Operating Cash Flow: 13157654 Open source
20182018-12-31	Operating cash flow	17730536	Operating Cash Flow: 17730536 Open source
20192019-12-31	Operating cash flow	22285149	Operating Cash Flow: 22285149 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(U001)	Source evidence
20102010-12-31	Free cash flow	Unavailable	Operating Cash Flow: -882482 Open source
20112011-12-31	Free cash flow	Unavailable	Operating Cash Flow: -687589 Open source
20122012-12-31	Free cash flow	Unavailable	Operating Cash Flow: 930433 Open source
20132013-12-31	Free cash flow	Unavailable	Operating Cash Flow: 4535549 Open source
20142014-12-31	Free cash flow	Unavailable	Operating Cash Flow: 6129176 Open source
20152015-12-31	Free cash flow	Unavailable	Operating Cash Flow: 10606660 Open source
20162016-12-31	Free cash flow	Unavailable	Operating Cash Flow: 16352349 Open source
20172017-12-31	Free cash flow	Unavailable	Operating Cash Flow: 13157654 Open source
20182018-12-31	Free cash flow	Unavailable	Operating Cash Flow: 17730536 Open source
20192019-12-31	Free cash flow	Unavailable	Operating Cash Flow: 22285149 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2010-12-31	Liabilities / assets	Not reported	No source recorded
2011-12-31	Liabilities / assets	Not reported	No source recorded
2012-12-31	Liabilities / assets	Not reported	No source recorded
2013-12-31	Liabilities / assets	Not reported	No source recorded
2014-12-31	Liabilities / assets	Not reported	No source recorded
2015-12-31	Liabilities / assets	Not reported	No source recorded
2016-12-31	Liabilities / assets	Not reported	No source recorded
2017-12-31	Liabilities / assets	Not reported	No source recorded
2018-12-31	Liabilities / assets	Not reported	No source recorded
2019-12-31	Liabilities / assets	Not reported	No source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2010-12-31	Current assets / current liabilities	Not reported	No source recorded
2011-12-31	Current assets / current liabilities	Not reported	No source recorded
2012-12-31	Current assets / current liabilities	Not reported	No source recorded
2013-12-31	Current assets / current liabilities	Not reported	No source recorded
2014-12-31	Current assets / current liabilities	Not reported	No source recorded
2015-12-31	Current assets / current liabilities	Not reported	No source recorded
2016-12-31	Current assets / current liabilities	Not reported	No source recorded
2017-12-31	Current assets / current liabilities	Not reported	No source recorded
2018-12-31	Current assets / current liabilities	Not reported	No source recorded
2019-12-31	Current assets / current liabilities	Not reported	No source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2010 2010-01-01 – 2010-12-31	−U001 1.51 million Exact value Exact value: -1508540 U001 2010-01-01 – 2010-12-31: -1508540 U001 Inspect Net Income Open source Share or cite Citation for Net Income · BIOSPECIFICS TECHNOLOGIES CORP · 2010-12-31 BIOSPECIFICS TECHNOLOGIES CORP (edgar:875622) Net Income: -1508540 U001 Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/875622/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=U001&dimensions= Input fundies:NetIncome: -1508540 U001 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036113012763/bstc-20121231.xml#394341 Filing: 000114036113012763 The citation records this snapshot. The page link may show a newer release later.	−U001 882,482 Exact value Exact value: -882482 U001 2010-01-01 – 2010-12-31: -882482 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOSPECIFICS TECHNOLOGIES CORP · 2010-12-31 BIOSPECIFICS TECHNOLOGIES CORP (edgar:875622) Operating Cash Flow: -882482 U001 Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/875622/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: -882482 U001 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036113012763/bstc-20121231.xml#398796 Filing: 000114036113012763 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2011 2011-01-01 – 2011-12-31	U001 6.6 million Exact value Exact value: 6601626 U001 2011-01-01 – 2011-12-31: 6601626 U001 Inspect Net Income Open source Share or cite Citation for Net Income · BIOSPECIFICS TECHNOLOGIES CORP · 2011-12-31 BIOSPECIFICS TECHNOLOGIES CORP (edgar:875622) Net Income: 6601626 U001 Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/875622/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=U001&dimensions= Input fundies:NetIncome: 6601626 U001 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036114011561/bstc-20131231.xml#409752 Filing: 000114036114011561 The citation records this snapshot. The page link may show a newer release later.	−U001 687,589 Exact value Exact value: -687589 U001 2011-01-01 – 2011-12-31: -687589 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOSPECIFICS TECHNOLOGIES CORP · 2011-12-31 BIOSPECIFICS TECHNOLOGIES CORP (edgar:875622) Operating Cash Flow: -687589 U001 Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/875622/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: -687589 U001 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036114011561/bstc-20131231.xml#413969 Filing: 000114036114011561 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2012 2012-01-01 – 2012-12-31	U001 2.98 million Exact value Exact value: 2981075 U001 2012-01-01 – 2012-12-31: 2981075 U001 Inspect Net Income Open source Share or cite Citation for Net Income · BIOSPECIFICS TECHNOLOGIES CORP · 2012-12-31 BIOSPECIFICS TECHNOLOGIES CORP (edgar:875622) Net Income: 2981075 U001 Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/875622/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=U001&dimensions= Input fundies:NetIncome: 2981075 U001 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036115011871/bstc-20141231.xml#457466 Filing: 000114036115011871 The citation records this snapshot. The page link may show a newer release later.	U001 930,433 Exact value Exact value: 930433 U001 2012-01-01 – 2012-12-31: 930433 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOSPECIFICS TECHNOLOGIES CORP · 2012-12-31 BIOSPECIFICS TECHNOLOGIES CORP (edgar:875622) Operating Cash Flow: 930433 U001 Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/875622/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: 930433 U001 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036115011871/bstc-20141231.xml#462400 Filing: 000114036115011871 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2013 2013-01-01 – 2013-12-31	U001 5.29 million Exact value Exact value: 5285847 U001 2013-01-01 – 2013-12-31: 5285847 U001 Inspect Net Income Open source Share or cite Citation for Net Income · BIOSPECIFICS TECHNOLOGIES CORP · 2013-12-31 BIOSPECIFICS TECHNOLOGIES CORP (edgar:875622) Net Income: 5285847 U001 Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/875622/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=U001&dimensions= Input fundies:NetIncome: 5285847 U001 (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036116057622/bstc-20151231.xml#522799 Filing: 000114036116057622 The citation records this snapshot. The page link may show a newer release later.	U001 4.54 million Exact value Exact value: 4535549 U001 2013-01-01 – 2013-12-31: 4535549 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOSPECIFICS TECHNOLOGIES CORP · 2013-12-31 BIOSPECIFICS TECHNOLOGIES CORP (edgar:875622) Operating Cash Flow: 4535549 U001 Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/875622/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: 4535549 U001 (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036116057622/bstc-20151231.xml#521764 Filing: 000114036116057622 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2014 2014-01-01 – 2014-12-31	U001 4.65 million Exact value Exact value: 4645960 U001 2014-01-01 – 2014-12-31: 4645960 U001 Inspect Net Income Open source Share or cite Citation for Net Income · BIOSPECIFICS TECHNOLOGIES CORP · 2014-12-31 BIOSPECIFICS TECHNOLOGIES CORP (edgar:875622) Net Income: 4645960 U001 Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/875622/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=U001&dimensions= Input fundies:NetIncome: 4645960 U001 (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036116057622/bstc-20151231.xml#522631 Filing: 000114036116057622 The citation records this snapshot. The page link may show a newer release later.	U001 6.13 million Exact value Exact value: 6129176 U001 2014-01-01 – 2014-12-31: 6129176 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOSPECIFICS TECHNOLOGIES CORP · 2014-12-31 BIOSPECIFICS TECHNOLOGIES CORP (edgar:875622) Operating Cash Flow: 6129176 U001 Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/875622/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: 6129176 U001 (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036116057622/bstc-20151231.xml#522365 Filing: 000114036116057622 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2015 2015-01-01 – 2015-12-31	U001 9.62 million Exact value Exact value: 9617632 U001 2015-01-01 – 2015-12-31: 9617632 U001 Inspect Net Income Open source Share or cite Citation for Net Income · BIOSPECIFICS TECHNOLOGIES CORP · 2015-12-31 BIOSPECIFICS TECHNOLOGIES CORP (edgar:875622) Net Income: 9617632 U001 Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/875622/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=U001&dimensions= Input fundies:NetIncome: 9617632 U001 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036118013423/bstc-20171231.xml#545043 Filing: 000114036118013423 The citation records this snapshot. The page link may show a newer release later.	U001 10.61 million Exact value Exact value: 10606660 U001 2015-01-01 – 2015-12-31: 10606660 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOSPECIFICS TECHNOLOGIES CORP · 2015-12-31 BIOSPECIFICS TECHNOLOGIES CORP (edgar:875622) Operating Cash Flow: 10606660 U001 Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/875622/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: 10606660 U001 (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036118013423/bstc-20171231.xml#544240 Filing: 000114036118013423 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2016-01-01 – 2016-12-31	U001 11.37 million Exact value Exact value: 11372239 U001 2016-01-01 – 2016-12-31: 11372239 U001 Inspect Net Income Open source Share or cite Citation for Net Income · BIOSPECIFICS TECHNOLOGIES CORP · 2016-12-31 BIOSPECIFICS TECHNOLOGIES CORP (edgar:875622) Net Income: 11372239 U001 Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/875622/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=U001&dimensions= Input fundies:NetIncome: 11372239 U001 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036119006323/bstc-20181231.xml#619994 Filing: 000114036119006323 The citation records this snapshot. The page link may show a newer release later.	U001 16.35 million Exact value Exact value: 16352349 U001 2016-01-01 – 2016-12-31: 16352349 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOSPECIFICS TECHNOLOGIES CORP · 2016-12-31 BIOSPECIFICS TECHNOLOGIES CORP (edgar:875622) Operating Cash Flow: 16352349 U001 Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/875622/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: 16352349 U001 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036119006323/bstc-20181231.xml#619191 Filing: 000114036119006323 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2017-01-01 – 2017-12-31	U001 11.33 million Exact value Exact value: 11328266 U001 2017-01-01 – 2017-12-31: 11328266 U001 Inspect Net Income Open source Share or cite Citation for Net Income · BIOSPECIFICS TECHNOLOGIES CORP · 2017-12-31 BIOSPECIFICS TECHNOLOGIES CORP (edgar:875622) Net Income: 11328266 U001 Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/875622/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=U001&dimensions= Input fundies:NetIncome: 11328266 U001 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036119006323/bstc-20181231.xml#619656 Filing: 000114036119006323 The citation records this snapshot. The page link may show a newer release later.	U001 13.16 million Exact value Exact value: 13157654 U001 2017-01-01 – 2017-12-31: 13157654 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOSPECIFICS TECHNOLOGIES CORP · 2017-12-31 BIOSPECIFICS TECHNOLOGIES CORP (edgar:875622) Operating Cash Flow: 13157654 U001 Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/875622/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: 13157654 U001 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036119006323/bstc-20181231.xml#619429 Filing: 000114036119006323 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2018 2018-01-01 – 2018-12-31	U001 20.05 million Exact value Exact value: 20053269 U001 2018-01-01 – 2018-12-31: 20053269 U001 Inspect Net Income Open source Share or cite Citation for Net Income · BIOSPECIFICS TECHNOLOGIES CORP · 2018-12-31 BIOSPECIFICS TECHNOLOGIES CORP (edgar:875622) Net Income: 20053269 U001 Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/875622/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=U001&dimensions= Input fundies:NetIncome: 20053269 U001 (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036120005848/bstc-20191231.xml#552752 Filing: 000114036120005848 The citation records this snapshot. The page link may show a newer release later.	U001 17.73 million Exact value Exact value: 17730536 U001 2018-01-01 – 2018-12-31: 17730536 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOSPECIFICS TECHNOLOGIES CORP · 2018-12-31 BIOSPECIFICS TECHNOLOGIES CORP (edgar:875622) Operating Cash Flow: 17730536 U001 Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/875622/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: 17730536 U001 (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036120005848/bstc-20191231.xml#551358 Filing: 000114036120005848 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2019 2019-01-01 – 2019-12-31	U001 24.47 million Exact value Exact value: 24469808 U001 2019-01-01 – 2019-12-31: 24469808 U001 Inspect Net Income Open source Share or cite Citation for Net Income · BIOSPECIFICS TECHNOLOGIES CORP · 2019-12-31 BIOSPECIFICS TECHNOLOGIES CORP (edgar:875622) Net Income: 24469808 U001 Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/875622/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=U001&dimensions= Input fundies:NetIncome: 24469808 U001 (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036120005848/bstc-20191231.xml#552964 Filing: 000114036120005848 The citation records this snapshot. The page link may show a newer release later.	U001 22.29 million Exact value Exact value: 22285149 U001 2019-01-01 – 2019-12-31: 22285149 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOSPECIFICS TECHNOLOGIES CORP · 2019-12-31 BIOSPECIFICS TECHNOLOGIES CORP (edgar:875622) Operating Cash Flow: 22285149 U001 Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/875622/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: 22285149 U001 (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/875622/000114036120005848/bstc-20191231.xml#551077 Filing: 000114036120005848 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

121 filings · 3,570 latest values · 3,570 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000875622, 875622, BSTC, edgar:875622

Also known as BIOSPECIFICS TECHNOLOGIES CORP, BIOSPECIFICS TECHNOLOGIES CORP

BIOSPECIFICS TECHNOLOGIES CORP

Latest quarter

Revenue

Operating margin

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2019 2019-01-01 – 2019-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation